FibroGen (FGEN) PT Lowered to $38 at Goldman Sachs
Tweet
Share
E-mailGet Alerts FGEN Hot Sheet
Price: $9.71 --0%
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 12
Rating Summary:
4 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 12
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on FibroGen (NASDAQ: FGEN) to $38.00 (from $46.00) while maintaining a Neutral rating.
You May Also Be Interested In
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
- Skandinaviska Enskilda Banken AB (SEBA:SS) (SKVKY) PT Raised to SEK190 at JPMorgan
- Svenska Handelsbanken AB (SHBA:SS) (SVNLY) PT Raised to SEK129 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
